Deciphering the molecular and cellular underpinnings of cognitive resilience in Alzheimer’s disease

Isabel Castanho, Pourya Naderi Yeganeh, Carles A. Boix, Hansruedi Mathys, Dmitry Prokopenko, Bartholomew White, Sarah Morgan, Christoph Lange, David A. Bennett, Lars Bertram, Rudolph E. Tanzi, Li‐Huei Tsai, Manolis Kellis, Yoshihide HayashizakiAlzheimer 2024 · DOI

TL;DR

This study investigates "cognitive resilience" in Alzheimer's disease (AD), where individuals maintain cognitive function despite significant AD pathology. By analyzing multi-modal data, researchers found that while bulk tissue gene expression in resilient individuals is similar to healthy aging, specific neuronal populations and interneurons show unique molecular signatures that may underlie this protective capacity. This work offers new targets for developing therapies to harness these natural protective mechanisms.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (Aβ) plaques and tau tangles in the brain, which typically leads to cognitive decline. However, a puzzling phenomenon known as "cognitive resilience" exists: some individuals exhibit substantial AD pathology at autopsy but show little to no cognitive impairment during their lifetime. Understanding the molecular and cellular mechanisms behind this resilience is crucial for developing effective AD treatments. This paper aims to uncover the biological underpinnings of cognitive resilience by identifying the specific molecular and cellular signatures that allow the brain to withstand AD pathology without compromising cognitive function.

Methods

The researchers employed a multi-modal approach, integrating data from the Religious Order Study and Memory and Aging Project (ROSMAP) cohort. Key techniques included:

  • Bulk RNA sequencing: This standard technique measures gene expression levels across entire tissue samples, providing a broad overview of molecular activity.
  • Multi-regional single nucleus RNA sequencing (snRNA-seq): This advanced method allows for the analysis of gene expression at the individual cell nucleus level, enabling the identification of cell-type-specific molecular profiles. This is a more granular approach than bulk RNA-seq and is crucial for dissecting cellular contributions.
  • Genetic risk profiling: The study assessed the genetic predisposition to AD in different subject groups.
  • Cellular distribution estimation: This involved analyzing the abundance of different cell types within the tissue samples.
  • Multiplex immunofluorescence: This technique allows for the simultaneous detection of multiple proteins within individual cells, helping to characterize specific cell populations and their molecular states.

The novelty lies in the integration of these diverse data types to connect genetic risk, bulk tissue expression, and fine-grained cellular phenotypes in the context of cognitive resilience.

Datasets

The study utilized data from the Religious Order Study and Memory and Aging Project (ROSMAP) cohort. This cohort provided:

  • Bulk RNA sequencing data from 631 subjects.
  • Multi-regional single nucleus RNA sequencing data from 48 subjects.

Subjects were categorized into three groups based on neuropathological findings (Aβ and tau levels) and cognitive status: Alzheimer's Disease (AD), Resilient, and Control.

Key Insights and Ideas

  • Resilience isn't just "no AD pathology": The study highlights that resilience is about maintaining cognitive function despite significant AD pathology, not the absence of it.
  • Bulk tissue tells only part of the story: At the whole-tissue level, resilient individuals' gene expression profiles are surprisingly similar to those of healthy aging individuals, masking the cellular-level adaptations.
  • Cellular specialization is key: The real story of resilience unfolds at the cellular level, with specific neuronal populations and interneurons playing distinct protective roles.
  • Interneurons as guardians: A particular subset of inhibitory neurons (interneurons) appears to be critical for protecting against AD-associated neuronal vulnerability, suggesting they are more than just modulators of neural activity.
  • Excitatory neurons have region-specific resilience: Specialized excitatory neuronal populations in specific brain regions (like the entorhinal cortex) exhibit resilience-like behaviors and express genes previously linked to cognitive resilience.

Key Results

  • Intermediate Genetic Risk: Resilient individuals showed a genetic risk profile that was intermediate between those with AD and healthy controls.
  • Limited Bulk Tissue Differences: Only two genes, GFAP and KLF4, were found to be differentially expressed between Resilient and Control subjects in bulk tissue analysis. GFAP was specifically upregulated in astrocytes within the dorsolateral prefrontal cortex of resilient individuals compared to both AD and control groups.
  • Neuronal Phenotypes: Both inhibitory and excitatory neurons displayed distinct, brain region-specific phenotypes associated with cognitive resilience.
  • Interneuron Enrichment: Somatostatin-positive interneurons were enriched for genes linked to protective rare genetic variants and showed vulnerability in AD, but this vulnerability was absent in resilient individuals.
  • Excitatory Neuron Resilience: Specific excitatory neuronal populations in the entorhinal cortex demonstrated resilience-like behavior and expressed genes previously associated with cognitive resilience.

Limitations and Future Work

  • Bulk vs. Cellular: The study acknowledges that while bulk tissue analysis shows minimal differences, the cellular-level findings are more pronounced. This highlights the need for high-resolution cellular analysis to truly understand resilience.
  • Translational Potential: The authors suggest that their findings provide direct insight into the molecular basis of cognitive resilience, yielding potential therapeutic targets. Future work could focus on validating these targets and exploring ways to convert natural protective systems into effective interventions for AD.
  • Causality: While the study identifies associations, further research would be needed to establish causal relationships between the observed molecular and cellular changes and cognitive resilience.

Summary updated

Abstract

Our findings suggest that at the bulk tissue transcriptome level, cognitive resilience does not exhibit marked gene expression differences from healthy aging, despite significant Aβ and tau neuropathology. At the cellular level, specialized excitatory neuronal populations may drive cognitive resilience, while a specific subset of interneurons may play a crucial role in other forms of protection against AD-associated neuronal vulnerability. This systematic study provides direct insight into the molecular basis of cognitive resilience, yielding targets offering the potential to convert natural protective systems into effective therapeutic interventions for AD.
BibTeX
@inproceedings{castanho2024deciphering,
  author = {Isabel Castanho and Pourya Naderi Yeganeh and Carles A. Boix and Hansruedi Mathys and Dmitry Prokopenko and Bartholomew White and Sarah Morgan and Christoph Lange and David A. Bennett and Lars Bertram and Rudolph E. Tanzi and Li‐Huei Tsai and Manolis Kellis and Yoshihide Hayashizaki},
  title = {{Deciphering the molecular and cellular underpinnings of cognitive resilience in Alzheimer’s disease}},
  booktitle = {Alzheimer},
  year = {2024},
  doi = {10.1002/alz.090374},
}
Figure